- call +1-201-465-4211
- email sales@mrinsights.biz
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
Scope of the Report:
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
The global Human Immunodeficiency Virus(HIV) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Immunodeficiency Virus(HIV).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Human Immunodeficiency Virus(HIV) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Immunodeficiency Virus(HIV) market by product type and applications/end industries.
Market Segment by Companies, this report covers
Gilead
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bristol-Myers Squibb
Boehringer Ingelheim
Genentech
Cipla
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diagnosis
Treatment
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Human Immunodeficiency Virus(HIV) Market Overview
1.1 Product Overview and Scope of Human Immunodeficiency Virus(HIV)
1.2 Classification of Human Immunodeficiency Virus(HIV) by Types
1.2.1 Global Human Immunodeficiency Virus(HIV) Revenue Comparison by Types (2017-2023)
1.2.2 Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Types in 2017
1.2.3 Diagnosis
1.2.4 Treatment
1.3 Global Human Immunodeficiency Virus(HIV) Market by Application
1.3.1 Global Human Immunodeficiency Virus(HIV) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Homecare Settings
1.3.6 Others
1.4 Global Human Immunodeficiency Virus(HIV) Market by Regions
1.4.1 Global Human Immunodeficiency Virus(HIV) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Human Immunodeficiency Virus(HIV) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Immunodeficiency Virus(HIV) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Immunodeficiency Virus(HIV) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Human Immunodeficiency Virus(HIV) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Immunodeficiency Virus(HIV) Status and Prospect (2013-2023)
1.5 Global Market Size of Human Immunodeficiency Virus(HIV) (2013-2023)
2 Manufacturers Profiles
2.1 Gilead
2.1.1 Business Overview
2.1.2 Human Immunodeficiency Virus(HIV) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gilead Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Human Immunodeficiency Virus(HIV) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Human Immunodeficiency Virus(HIV) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Human Immunodeficiency Virus(HIV) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2016-2017)
2.5 AbbVie
2.5.1 Business Overview
2.5.2 Human Immunodeficiency Virus(HIV) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AbbVie Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb
2.6.1 Business Overview
2.6.2 Human Immunodeficiency Virus(HIV) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Boehringer Ingelheim
2.7.1 Business Overview
2.7.2 Human Immunodeficiency Virus(HIV) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boehringer Ingelheim Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Genentech
2.8.1 Business Overview
2.8.2 Human Immunodeficiency Virus(HIV) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Genentech Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cipla
2.9.1 Business Overview
2.9.2 Human Immunodeficiency Virus(HIV) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cipla Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Immunodeficiency Virus(HIV) Market Competition, by Players
3.1 Global Human Immunodeficiency Virus(HIV) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Immunodeficiency Virus(HIV) Players Market Share
3.2.2 Top 10 Human Immunodeficiency Virus(HIV) Players Market Share
3.3 Market Competition Trend
4 Global Human Immunodeficiency Virus(HIV) Market Size by Regions
4.1 Global Human Immunodeficiency Virus(HIV) Revenue and Market Share by Regions
4.2 North America Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
4.3 Europe Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
4.5 South America Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
5 North America Human Immunodeficiency Virus(HIV) Revenue by Countries
5.1 North America Human Immunodeficiency Virus(HIV) Revenue by Countries (2013-2018)
5.2 USA Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
5.3 Canada Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
5.4 Mexico Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
6 Europe Human Immunodeficiency Virus(HIV) Revenue by Countries
6.1 Europe Human Immunodeficiency Virus(HIV) Revenue by Countries (2013-2018)
6.2 Germany Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
6.3 UK Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
6.4 France Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
6.5 Russia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
6.6 Italy Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue by Countries
7.1 Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue by Countries (2013-2018)
7.2 China Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
7.3 Japan Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
7.4 Korea Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
7.5 India Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
8 South America Human Immunodeficiency Virus(HIV) Revenue by Countries
8.1 South America Human Immunodeficiency Virus(HIV) Revenue by Countries (2013-2018)
8.2 Brazil Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
8.3 Argentina Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
8.4 Colombia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Human Immunodeficiency Virus(HIV) by Countries
9.1 Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
9.3 UAE Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
9.4 Egypt Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
9.6 South Africa Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2013-2018)
10 Global Human Immunodeficiency Virus(HIV) Market Segment by Type
10.1 Global Human Immunodeficiency Virus(HIV) Revenue and Market Share by Type (2013-2018)
10.2 Global Human Immunodeficiency Virus(HIV) Market Forecast by Type (2018-2023)
10.3 Diagnosis Revenue Growth Rate (2013-2023)
10.4 Treatment Revenue Growth Rate (2013-2023)
11 Global Human Immunodeficiency Virus(HIV) Market Segment by Application
11.1 Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Application (2013-2018)
11.2 Human Immunodeficiency Virus(HIV) Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
11.6 Homecare Settings Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Human Immunodeficiency Virus(HIV) Market Size Forecast (2018-2023)
12.1 Global Human Immunodeficiency Virus(HIV) Market Size Forecast (2018-2023)
12.2 Global Human Immunodeficiency Virus(HIV) Market Forecast by Regions (2018-2023)
12.3 North America Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2018-2023)
12.4 Europe Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2018-2023)
12.6 South America Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Human Immunodeficiency Virus(HIV) Picture
Table Product Specifications of Human Immunodeficiency Virus(HIV)
Table Global Human Immunodeficiency Virus(HIV) and Revenu
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
